BioDelivery Sciences (BDSI) Misses Q4 EPS by 5c

March 15, 2018 4:02 PM EDT

BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of ($0.29), $0.05 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $9.77 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings